Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study

Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study

Background Neoadjuvant chemotherapy (NACT) and neoadjuvant chemoradiotherapy (NACRT) have been demonstrated to improve survival compared to surgery alone in esophageal carcinoma, but the evidence is scarce on which of these therapies is more beneficial, particularly with regard to resectability rat...

Full description

Bibliographic Details
Main Authors: Syed Nusrath, Subramanyeshwar Rao Thammineedi, Vijaya Narsimha Raju, Sujit Chyau Patnaik, Satish Pawar, Ayyagari Santa, Senthil J. Rajappa, Krishna Mohan Mallavarapu, Krishnam Raju, Sudha Murthy
Format: Article
Language:English
Published: Rambam Health Care Campus 2019-01-01
Series:Rambam Maimonides Medical Journal
Subjects:
Esophagectomy
neoadjuvant chemoradiotherapy
neoadjuvant chemotherapy
resectability
Online Access:https://www.rmmj.org.il/issues/40/856/manuscript

Internet

https://www.rmmj.org.il/issues/40/856/manuscript

Similar Items